2022 Annual Meeting | C36 - Endovascular Management of Ischemic and Hemorrhagic Stroke

Date Sunday 04/03/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Johanna T. Fifi, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives During this course participants will review the evaluation and management of posterior ciculation stroke including the use of thrombectomy; discuss ethical considerations in relationship to recent trials in posterior ciculation stroke; discuss current stroke systems of care and organization of thrombectomy services; discuss new advances in the management of aneurysms and arteriovenous malformations.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Introduction Johanna T. Fifi, MD, FAAN
07:00 AM - 09:00 AM PDT	Speaker	walk in slides Johanna T. Fifi, MD, FAAN
07:05 AM - 07:35 AM PDT	Speaker	What's BASIC and BEST for Posterior Circulation Stroke: Review and Update on Recent Trials Maryna Skliut, MD
07:35 AM - 08:05 AM PDT	Speaker	Innovations in Stroke Systems of Care Johanna T. Fifi, MD, FAAN
08:05 AM - 08:35 AM PDT	Speaker	Update on Cerebral Aneurysms and Hemorrhage Dorothea Altschul, MD
08:35 AM - 09:00 AM PDT	Speaker	Cases and Discussion Johanna T. Fifi, MD, FAAN, Dorothea Altschul, MD, Maryna Skliut, MD

Faculty Disclosures
Johanna T. Fifi, MD, FAAN	Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Dorothea Altschul, MD	An immediate family member of Dr. Altschul has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention and stryker . Dr. Altschul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. The institution of Dr. Altschul has received research support from Max Kade .
Maryna Skliut, MD	Dr. Skliut has nothing to disclose.